Henry Schein raises 2026 EPS outlook to $5.29-$5.39 on stronger sales growth

seekingalpha.com

Henry Schein raised its full-year 2026 earnings per share guidance to $5.29-$5.39 and lifted its sales growth outlook to 4.5%-5.5%, citing strong second-quarter performance and sustained momentum. The company reported robust sales and margin improvement in Q2 2026, driven by cost initiatives and continued adoption of its Dentrix Ascend software platform. Management credited first-half results for enabling the upward revision. The revised EPS range reflects confidence in ongoing operational efficiency gains. Henry Schein, a healthcare products distributor, expects these trends to persist through the remainder of the year.


With a significance score of 1.4, this news ranks in the top 36% of today's 29840 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Henry Schein raises 2026 EPS outlook to $5.29-$5.39 on stronger sales growth | News Minimalist